<DOC>
	<DOCNO>NCT00311311</DOCNO>
	<brief_summary>The purpose study determine whether immunosuppression tacrolimus , mycophenolate mofetil , prednisone compare conversion sirolimus , mycophenolate mofetil , prednisone affect progression atherosclerosis renal transplant recipient .</brief_summary>
	<brief_title>Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients</brief_title>
	<detailed_description>A decision terminate study take November 2011 communication effect send participate site November 18 . All site ask patient return site end study procedure perform Dec 31 , 2011 . The decision terminate study make follow conduct interim analysis demonstrate study reach primary endpoint . The termination study drive safety concern impact subject safety well-being .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>At least one follow characteristic : History dialysis least 3 year . History diabetes least 5 year . Hypertension ischemic nephropathy cause end stage renal disease loss first transplant . History coronary artery disease , stroke , myocardial infarction , amputation vascular disease . History malignancy within last 5 year ( except adequately treated skin cancer ) . Recipients nonrenal organ transplant . Active gastrointestinal disease may interfere drug absorption . Active HIV , hepatitis B C infection . Women pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Kidney transplant</keyword>
	<keyword>Renal transplant</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Graft Rejection</keyword>
</DOC>